GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemagen Diagnostics Inc (OTCPK:HMGN) » Definitions » Cyclically Adjusted PB Ratio

Hemagen Diagnostics (Hemagen Diagnostics) Cyclically Adjusted PB Ratio : (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Hemagen Diagnostics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hemagen Diagnostics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hemagen Diagnostics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemagen Diagnostics Cyclically Adjusted PB Ratio Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hemagen Diagnostics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Hemagen Diagnostics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemagen Diagnostics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's Cyclically Adjusted PB Ratio falls into.



Hemagen Diagnostics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hemagen Diagnostics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2012 is calculated as:

For example, Hemagen Diagnostics's adjusted Book Value per Share data for the three months ended in Sep. 2012 was:

Adj_Book=Book Value per Share/CPI of Sep. 2012 (Change)*Current CPI (Sep. 2012)
=-0.228/97.6331*97.6331
=-0.228

Current CPI (Sep. 2012) = 97.6331.

Hemagen Diagnostics Quarterly Data

Book Value per Share CPI Adj_Book
200212 0.280 76.324 0.358
200303 0.236 77.716 0.296
200306 0.199 77.505 0.251
200309 0.190 78.138 0.237
200312 0.133 77.758 0.167
200403 0.095 79.066 0.117
200406 0.024 80.037 0.029
200409 0.026 80.121 0.032
200412 0.001 80.290 0.001
200503 -0.024 81.555 -0.029
200506 -0.036 82.062 -0.043
200509 -0.067 83.876 -0.078
200512 -0.059 83.032 -0.069
200603 -0.063 84.298 -0.073
200606 -0.071 85.606 -0.081
200609 -0.046 85.606 -0.052
200612 -0.070 85.142 -0.080
200703 -0.089 86.640 -0.100
200706 -0.097 87.906 -0.108
200709 -0.098 87.964 -0.109
200712 -0.046 88.616 -0.051
200803 -0.043 90.090 -0.047
200806 -0.043 92.320 -0.045
200809 -0.072 92.307 -0.076
200812 -0.098 88.697 -0.108
200903 -0.107 89.744 -0.116
200906 -0.109 91.003 -0.117
200909 -0.117 91.120 -0.125
200912 -0.120 91.111 -0.129
201003 -0.118 91.821 -0.125
201006 -0.118 91.962 -0.125
201009 -0.119 92.162 -0.126
201012 -0.129 92.474 -0.136
201103 -0.149 94.283 -0.154
201106 -0.147 95.235 -0.151
201109 -0.172 95.727 -0.175
201112 -0.196 95.213 -0.201
201203 -0.208 96.783 -0.210
201206 -0.220 96.819 -0.222
201209 -0.228 97.633 -0.228

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hemagen Diagnostics  (OTCPK:HMGN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hemagen Diagnostics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hemagen Diagnostics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hemagen Diagnostics (Hemagen Diagnostics) Business Description

Traded in Other Exchanges
N/A
Address
9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.
Executives
Howard F Curd director

Hemagen Diagnostics (Hemagen Diagnostics) Headlines

No Headlines